Sign In
Buy EVOK
$11.00
+0 (+0%)
At Close: Mar 16, 2026
Evoke Pharma Announces the Appointment of Greg Pyszczymuka to the Board of Directors
08:30am, Monday, 24'th Feb 2025
SOLANA BEACH, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an
William Hill owner Evoke expects earnings to beat market forecasts
02:53am, Friday, 17'th Jan 2025
Expect shares in William Hill owner Evoke PLC to get off to a strong start when the market opens. That's because the bookmaker said full-year earnings for 2024 will surpass market expectations, with
Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends
08:30am, Thursday, 19'th Dec 2024
FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025 Gimoti remains only approved drug shown to reduce hospitalizations, emergency room and medical offi
Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI®
08:30am, Tuesday, 03'rd Dec 2024
SOLANA BEACH, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an
Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
04:05pm, Thursday, 07'th Nov 2024
GIMOTI third quarter net product sales of $2.7 million, highest quarterly revenue ever with a 70% increase year-over-year
Ladbrokes and William Hill owners Entain and Evoke jump on Budget relief
12:16pm, Wednesday, 30'th Oct 2024
Shares in bookmakers galloped higher after the UK Budget, led by Ladbrokes and Coral owner Entain PLC (LSE:ENT), which rose over 8%, and William Hill owner Evoke PLC, rising 12%. Paddy Power and Betf
Evoke Pharma to Showcase Award-Winning Research at the 2024 American College of Gastroenterology Annual Scientific Meeting
08:30am, Wednesday, 23'rd Oct 2024
SOLANA BEACH, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with a
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
08:30am, Tuesday, 22'nd Oct 2024
SOLANA BEACH, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with a
Evoke reports first quarter of growth in over two years
03:43am, Friday, 18'th Oct 2024
William Hill and 888 owner Evoke PLC (LSE:EVOK) has reported a 3% increase in revenue to £417 million for the third quarter of 2024, compared to the same period last year. It highlighted that this ma
Bookmakers Entain, Flutter, Evoke and Rank tumble on new gambling tax reports
03:25am, Monday, 14'th Oct 2024
Shares in listed bookmakers Entain PLC (LSE:ENT), Flutter Entertainment PLC (LSE:FLTR) and Evoke PLC (LSE:EVOK) tumbled on the back of news that the UK government might target the sector in this m
Evoke Pharma Announces Proceeds from Existing Warrants and Board Expansion
08:30am, Tuesday, 01'st Oct 2024
Nantahala to nominate 2 board seats Portion of the proceeds received from warrants executed at $8.16/share SOLANA BEACH, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a
Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments
02:20pm, Thursday, 19'th Sep 2024
Gimoti remains the sole proprietary FDA approved treatment for symptoms of diabetic gastroparesis Gimoti remains the sole proprietary FDA approved treatment for symptoms of diabetic gastroparesis
XLR8 America and EVoke Systems Partner to Deliver Smarter EV Charging Stations to the Parking Industry
04:00pm, Wednesday, 18'th Sep 2024
SAN DIEGO--(BUSINESS WIRE)-- #CleanTech--EVoke Partnership.
Evoke Pharma to Participate in Gastroenterology and Hepatology Advanced Practice Providers (GHAPP) Annual Conference
08:30am, Monday, 09'th Sep 2024
SOLANA BEACH, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with
Evoke Pharma to Present at H.C. Wainwright's 26th Annual Global Investment Conference
09:20am, Wednesday, 04'th Sep 2024
SOLANA BEACH, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with
